- Wegovy cuts risk of serious heart problems by 20%: landmark study New York Post
- Novo Nordisk: Wegovy heart benefits due to more than weight loss Reuters
- Wegovy Weight Loss Drug Cuts Heart Complication Risk, Says Trial – Novo Nordisk (NYSE:NVO), Eli Lilly (NY Benzinga
- How some weight loss drugs fight against heart disease Good Morning America
- Wegovy drug study bolsters use in patients with obesity, heart disease The Seattle Times
Source: Wegovy cuts risk of serious heart problems by 20%: landmark study – New York Post


